dapsone has been researched along with Arthritis, Rheumatoid in 49 studies
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty patients with active rheumatoid arthritis (RA) entered a double-blind randomized study of 24 weeks duration, to compare the efficacy and toxicity of hydroxychloroquine, dapsone, and a combination of both drugs in treatment of RA." | 9.07 | A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. ( Christensen, L; Haar, D; Hansen, TM; Rasmussen, KJ; Sølvkjaer, M; Unger, B, 1993) |
| "Dapsone given over 14 weeks in a dose of 50 mg a day for 1 week and thereafter 100 mg a day was found to have a beneficial effect in rheumatoid arthritis when compared with placebo administration to a matched group of patients." | 9.05 | Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis. ( Jackson, L; Swinson, DR; Zlosnick, J, 1981) |
| "After a preliminary period of observation, 71 patients with consistently active rheumatoid arthritis (RA) were given dapsone 50 mg daily for one week, then 100 mg daily." | 9.04 | Dapsone in rheumatoid arthritis. ( Butler, M; Constable, TJ; Crockson, AP; Crockson, RA; Davies, P; McConkey, B, 1976) |
| "The dapsone recovery ratio and the 14C erythromycin breath test were correlated with cyclosporine concentrations in 16 patients with rheumatoid arthritis to determine the usefulness of the dapsone recovery ratio as an alternative to the 14C erythromycin breath test." | 7.69 | Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine. ( Kinirons, MT; Pincus, T; Stein, CM; Wilkinson, GR; Wood, AJ, 1996) |
| "The outcome of attempts to continue treatment indefinitely with either gold, penicillamine, sulphasalazine, or dapsone was studied in 240 patients with rheumatoid arthritis (RA)." | 7.67 | Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. ( Grindulis, KA; McConkey, B, 1984) |
| "Hemoglobin concentration (Hb) was measured at 6 week intervals for up to a year in 84 patients with rheumatoid arthritis treated with dapsone." | 7.67 | Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin. ( Grindulis, KA; McConkey, B, 1984) |
| "The acetylator phenotype was determined in 59 patients with classical, seropositive and erosive rheumatoid arthritis (RA) treated with sodium-aurothiomalate or d-penicillamine." | 7.67 | Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine. ( Mjörndal, T; Rantapää Dahlqvist, S, 1987) |
| "Cross-sectional and longitudinal studies have been carried out to determine the incidence and clinical significance of eosinophilia in patients taking penicillamine for rheumatoid arthritis." | 7.66 | Eosinophilia in D-penicillamine therapy. ( Scott, DL; Smith, DH; Zaphiropoulos, GC, 1983) |
| "Acetylator phenotype was determined in 54 patients with rheumatoid arthritis (RA) taking dapsone in the course of 2 comparative clinical studies." | 7.66 | Acetylator phenotype and the effect of dapsone in rheumatoid arthritis. ( Crook, PR; Hortas, C; Mucklow, JC; Roberts, EJ; Shadforth, MF; Swinson, DR, 1983) |
| "Sequential measurements of serum C-reactive protein (CRP), serum haptoglobin (Hp), and erythrocyte sedimentation rate (ESR) were made in 209 patients with rheumatoid arthritis (RA); 78 of them were treated with gold, 71 with dapsone, and 60 with prednisone." | 7.66 | Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. ( Amos, RS; Butler, M; Constable, TJ; Crockson, AP; Crockson, RA; Davies, P; McConkey, B, 1979) |
| "Eighty patients with active rheumatoid arthritis (RA) entered a double-blind randomized study of 24 weeks duration, to compare the efficacy and toxicity of hydroxychloroquine, dapsone, and a combination of both drugs in treatment of RA." | 5.07 | A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. ( Christensen, L; Haar, D; Hansen, TM; Rasmussen, KJ; Sølvkjaer, M; Unger, B, 1993) |
| "Dapsone given over 14 weeks in a dose of 50 mg a day for 1 week and thereafter 100 mg a day was found to have a beneficial effect in rheumatoid arthritis when compared with placebo administration to a matched group of patients." | 5.05 | Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis. ( Jackson, L; Swinson, DR; Zlosnick, J, 1981) |
| "After a preliminary period of observation, 71 patients with consistently active rheumatoid arthritis (RA) were given dapsone 50 mg daily for one week, then 100 mg daily." | 5.04 | Dapsone in rheumatoid arthritis. ( Butler, M; Constable, TJ; Crockson, AP; Crockson, RA; Davies, P; McConkey, B, 1976) |
| "The dapsone recovery ratio and the 14C erythromycin breath test were correlated with cyclosporine concentrations in 16 patients with rheumatoid arthritis to determine the usefulness of the dapsone recovery ratio as an alternative to the 14C erythromycin breath test." | 3.69 | Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine. ( Kinirons, MT; Pincus, T; Stein, CM; Wilkinson, GR; Wood, AJ, 1996) |
| "The outcome of attempts to continue treatment indefinitely with either gold, penicillamine, sulphasalazine, or dapsone was studied in 240 patients with rheumatoid arthritis (RA)." | 3.67 | Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. ( Grindulis, KA; McConkey, B, 1984) |
| "Hemoglobin concentration (Hb) was measured at 6 week intervals for up to a year in 84 patients with rheumatoid arthritis treated with dapsone." | 3.67 | Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin. ( Grindulis, KA; McConkey, B, 1984) |
| "The acetylator phenotype was determined in 59 patients with classical, seropositive and erosive rheumatoid arthritis (RA) treated with sodium-aurothiomalate or d-penicillamine." | 3.67 | Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine. ( Mjörndal, T; Rantapää Dahlqvist, S, 1987) |
| "One hundred and fifty consecutive patients with active, rheumatoid arthritis were assessed and treated with gold, D-penicillamine, chloroquine or dapsone." | 3.67 | Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. ( Clarke, S; Dawes, PT; Fisher, J; Fowler, PD; Lawton, A; Shadforth, MF, 1986) |
| "Cross-sectional and longitudinal studies have been carried out to determine the incidence and clinical significance of eosinophilia in patients taking penicillamine for rheumatoid arthritis." | 3.66 | Eosinophilia in D-penicillamine therapy. ( Scott, DL; Smith, DH; Zaphiropoulos, GC, 1983) |
| "Acetylator phenotype was determined in 54 patients with rheumatoid arthritis (RA) taking dapsone in the course of 2 comparative clinical studies." | 3.66 | Acetylator phenotype and the effect of dapsone in rheumatoid arthritis. ( Crook, PR; Hortas, C; Mucklow, JC; Roberts, EJ; Shadforth, MF; Swinson, DR, 1983) |
| "Sequential measurements of serum C-reactive protein (CRP), serum haptoglobin (Hp), and erythrocyte sedimentation rate (ESR) were made in 209 patients with rheumatoid arthritis (RA); 78 of them were treated with gold, 71 with dapsone, and 60 with prednisone." | 3.66 | Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. ( Amos, RS; Butler, M; Constable, TJ; Crockson, AP; Crockson, RA; Davies, P; McConkey, B, 1979) |
| "Cancer was found to be associated with 9." | 2.61 | Erythema elevatum diutinum: a case report and review of literature. ( Doktor, V; Goodheart, H; Hadi, A; Phelps, R, 2019) |
| "We report a case of subcorneal pustular dermatosis (SPD) in a patient with rheumatoid arthritis (RA) and diffuse scleroderma." | 1.35 | Subcorneal pustular dermatosis in a patient with rheumatoid arthritis and diffuse scleroderma. ( Brantley, EI; Sheth, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (61.22) | 18.7374 |
| 1990's | 7 (14.29) | 18.2507 |
| 2000's | 5 (10.20) | 29.6817 |
| 2010's | 6 (12.24) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Kerroum, S | 1 |
| Ammar, N | 1 |
| Znati, K | 1 |
| Ismaili, N | 1 |
| Meziane, M | 1 |
| Benzekri, L | 1 |
| Senouci, K | 1 |
| Doktor, V | 1 |
| Hadi, A | 2 |
| Phelps, R | 1 |
| Goodheart, H | 1 |
| Nambiar, PH | 1 |
| Katikaneni, M | 1 |
| Al Nahlawi, B | 1 |
| Hayat, SQ | 1 |
| Ker, KJ | 1 |
| Pan, JY | 1 |
| Lui, NL | 1 |
| Tey, HL | 1 |
| Brantley, EI | 1 |
| Sheth, P | 1 |
| Rushing, EC | 1 |
| Hoschar, AP | 1 |
| McDonnell, JK | 1 |
| Billings, SD | 1 |
| Lluch, P | 1 |
| Urruticoechea, A | 1 |
| Lluch, J | 1 |
| Moll, MC | 1 |
| Matos, M | 1 |
| Benet, JM | 1 |
| Ene, L | 1 |
| Cañete, JD | 1 |
| Fujio, Y | 1 |
| Funakoshi, T | 1 |
| Nakayama, K | 1 |
| Amagai, M | 1 |
| Ohyama, M | 1 |
| Lu, CI | 1 |
| Yang, CH | 1 |
| Hong, HS | 1 |
| Bremner, R | 1 |
| Simpson, E | 1 |
| White, CR | 1 |
| Morrison, L | 1 |
| Deodhar, A | 1 |
| Aydog, E | 1 |
| Yesilli, O | 1 |
| Sever, A | 1 |
| Usan, H | 1 |
| Bukhari, IA | 1 |
| Wright, V | 1 |
| Amos, R | 1 |
| McConkey, B | 6 |
| Crook, PR | 3 |
| Fowler, PD | 4 |
| Shadforth, MF | 4 |
| Smith, DH | 1 |
| Scott, DL | 2 |
| Zaphiropoulos, GC | 1 |
| Grindulis, KA | 3 |
| Sonne, M | 1 |
| Lawton, A | 2 |
| Trnavski, K | 1 |
| Hortas, C | 1 |
| Roberts, EJ | 1 |
| Swinson, DR | 2 |
| Mucklow, JC | 1 |
| Ehrenfeld, M | 1 |
| Zylber-Katz, E | 1 |
| Levy, M | 1 |
| Zlosnick, J | 1 |
| Jackson, L | 1 |
| Leden, I | 1 |
| Hanson, A | 1 |
| Melander, A | 1 |
| Sturfelt, G | 1 |
| Svensson, B | 1 |
| Wàhlin-Boll, E | 1 |
| Kelly, C | 1 |
| Griffiths, ID | 1 |
| Haar, D | 1 |
| Sølvkjaer, M | 1 |
| Unger, B | 1 |
| Rasmussen, KJ | 1 |
| Christensen, L | 1 |
| Hansen, TM | 1 |
| Stein, CM | 1 |
| Kinirons, MT | 1 |
| Pincus, T | 1 |
| Wilkinson, GR | 1 |
| Wood, AJ | 1 |
| Hughes, JR | 1 |
| Erhardt, CC | 1 |
| Clement, M | 1 |
| Chang, DJ | 1 |
| Lamothe, M | 1 |
| Stevens, RM | 1 |
| Sigal, LH | 1 |
| Fukuhara, K | 1 |
| Urano, Y | 1 |
| Kimura, S | 1 |
| Hori, K | 1 |
| Arase, S | 1 |
| Nakajima, H | 1 |
| Ikeda, M | 1 |
| Yamamoto, Y | 1 |
| Kodama, H | 1 |
| Capstick, RB | 1 |
| Lewis, DA | 1 |
| Best, R | 1 |
| Davies, P | 2 |
| Crockson, RA | 2 |
| Crockson, AP | 2 |
| Butler, M | 2 |
| Constable, TJ | 2 |
| Amos, RS | 1 |
| Ansell, BM | 1 |
| Olsen, TG | 1 |
| Wright, RC | 1 |
| Lester, AI | 1 |
| Tanzer, FR | 1 |
| Lynfield, YL | 1 |
| Roger, H | 1 |
| Thevenet, JP | 1 |
| Souteyrand, P | 1 |
| Sauvezie, B | 1 |
| Job-Deslandre, C | 1 |
| Menkès, CJ | 1 |
| Eulry, F | 1 |
| Pattin, S | 1 |
| Auzanneau, G | 1 |
| Martoia, R | 1 |
| Doury, P | 2 |
| Rantapää Dahlqvist, S | 1 |
| Mjörndal, T | 1 |
| Bernard, P | 1 |
| Arnaud, M | 2 |
| Treves, R | 2 |
| Bonnetblanc, JM | 1 |
| Dawes, PT | 2 |
| Shadforth, M | 1 |
| Bacon, PA | 1 |
| Clarke, S | 1 |
| Fisher, J | 1 |
| Ryzen, E | 1 |
| Singer, FR | 1 |
| Jacob, P | 1 |
| Tabaraud, F | 1 |
| Archambeaud-Mouveroux, F | 1 |
| Burki, F | 1 |
| Desproges-Gotteron, R | 1 |
4 reviews available for dapsone and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Erythema elevatum diutinum: a case report and review of literature.
Topics: Arthritis, Rheumatoid; Comorbidity; Dapsone; Folic Acid Antagonists; HIV Infections; Humans; Male; M | 2019 |
Rheumatoid neutrophilic dermatosis with tense blister formation: a case report and review of the literature.
Topics: Aged; Anti-Infective Agents; Arthritis, Rheumatoid; Blister; Dapsone; Dermatitis; Female; Humans; Ne | 2014 |
Do drugs change the course of rheumatoid arthritis?
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; C-Reactive Protein; Chloroquine; Cyclophos | 1980 |
Dapsone in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trial | 1996 |
8 trials available for dapsone and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Treatment of rheumatoid arthritis with dapsone].
Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Dapsone; Double-Blind Method; Female; | 1983 |
Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Chloroquine; Clinical Trials as Topic; Dapsone; Female; H | 1984 |
Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Dapsone; Double-Blind Method; Female; Humans | 1981 |
A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthrography; Blood Sedimentation; C-Reactive | 1993 |
Dapsone in rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Clinical Trials as Topic; Dapsone; Female; Gold; Humans; Male; Time | 1976 |
[Treatment of rheumatoid polyarthritis with dapsone. A controlled study versus placebo].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Dapsone; Double-Blind Method; Female; Follow-Up Stu | 1989 |
Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Blood Sedimentation; Ch | 1985 |
[Dapsone in the treatment of rheumatoid polyarthritis. Double-blind study (11 cases) and open study (7 cases)].
Topics: Arthritis, Rheumatoid; Dapsone; Double-Blind Method; Drug Evaluation; Female; Humans; Male | 1985 |
37 other studies available for dapsone and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Sneddon-Wilkinson disease: a case report].
Topics: Arthritis, Rheumatoid; Blister; Dapsone; Dermatitis; Humans; Middle Aged; Skin Diseases, Vesiculobul | 2022 |
Leprosy after interleukin 6 inhibitor therapy in a patient with rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Dapsone; Exanthema; Female; Humans; Lepros | 2019 |
An under-recognized cause of polyarthritis: leprosy.
Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Clofazimine; Dapsone; Delayed Diagnosis; | 2013 |
Subcorneal pustular dermatosis in a patient with rheumatoid arthritis and diffuse scleroderma.
Topics: Adult; Arthritis, Rheumatoid; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Female; Hu | 2009 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clo | 2011 |
Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Dapsone; Drug Substitution; Etanercept; Female; | 2012 |
A bullous neutrophilic dermatosis in a patient with severe rheumatoid arthritis and monoclonal IgA gammopathy.
Topics: Adult; Arthritis, Rheumatoid; Biopsy; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Hu | 2004 |
Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders.
Topics: Adult; Arthritis, Rheumatoid; Dapsone; Dermatitis; Drug Therapy, Combination; Female; Granuloma; Hum | 2004 |
Dermatitis herpetiformis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, | 2006 |
Dermatitis herpetiformis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Dapsone; Dermatitis Herpetif | 2007 |
Adverse reactions to dapsone.
Topics: Adult; Agranulocytosis; Arthritis, Rheumatoid; Child; Dapsone; Humans | 1981 |
Errors in prescribing dapsone.
Topics: Arthritis, Rheumatoid; Dapsone; Drug Combinations; Humans; Medication Errors; Pyrimethamine | 1981 |
Eosinophilia in D-penicillamine therapy.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; Dapsone; Eosinophilia; Fem | 1983 |
Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Gold Sodium Thiomalate; Humans; Mal | 1984 |
[Drugs capable of altering the course of rheumatoid arthritis].
Topics: Antimalarials; Arthritis, Rheumatoid; Dapsone; Gold; Humans; Immunization, Passive; Levamisole; Meta | 1984 |
Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin.
Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Dapsone; Female; Hemoglobins; Humans; Male; Middle Aged; | 1984 |
Acetylator phenotype and the effect of dapsone in rheumatoid arthritis.
Topics: Acetylation; Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Male; Middle Aged; Phenoty | 1983 |
Acetylator phenotype in rheumatoid arthritis.
Topics: Acetylation; Acetyltransferases; Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Male; | 1983 |
Varying distribution of acetylation phenotypes in RA patients with and without Sjögren's syndrome.
Topics: Acetylation; Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Isoniazid; Male; Middle Ag | 1981 |
Dapsone in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Dapsone; Humans | 1981 |
Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Breath Tests; Carbon Radioisotopes; Cyclos | 1996 |
Neutrophilic dermatosis in association with rheumatoid arthritis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; Drug | 1995 |
Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; Female; Humans; Lung | 1998 |
Erythema elevatum diutinum complicated by rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; E | 1999 |
Proceedings: Anti-inflammatory properties of dapsone.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Dapsone; Edema; Male; Prednisolone; Rats; | 1975 |
If I had... Severe rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Dapsone; Gold; Humans; Pen | 1978 |
Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Dapsone; Gold Sodium Thiomalate; Hap | 1979 |
Some aspects of slow-acting drugs in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Dapsone; Gold; Humans; Immunosuppression Therapy; Levamisole; Pe | 1979 |
Subcorneal pustular dermatosis and crippling arthritis.
Topics: Adult; Arthritis, Rheumatoid; Dapsone; Female; Humans; Skin; Skin Diseases | 1979 |
Erythema elevatum diutinum.
Topics: Aged; Arthritis, Rheumatoid; Dapsone; Erythema; Humans; Leg Ulcer; Male; Prednisone; Skin Diseases; | 1978 |
Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment.
Topics: Adult; Arthritis, Rheumatoid; Dapsone; Female; Humans; Immunoglobulin A; Rheumatoid Factor; Skin Dis | 1990 |
[Agranulocytosis caused by dapsone in rheumatoid arthritis].
Topics: Aged; Agranulocytosis; Arthritis, Rheumatoid; Dapsone; Female; Humans | 1989 |
[Dapsone in rheumatology].
Topics: Arthritis, Rheumatoid; Dapsone; Giant Cell Arteritis; Humans; Polychondritis, Relapsing; Polymyalgia | 1986 |
Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine.
Topics: Acetylation; Adult; Aged; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Dapsone; Fema | 1987 |
Dapsone and rheumatoid vasculitis leg ulcerations.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Leg Ulcer; Vasculitis | 1988 |
Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
Topics: Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chloroquine; Dapsone; Drug Evaluatio | 1986 |
Hypercalcemia in leprosy.
Topics: Arthritis, Rheumatoid; Calcitonin; Calcium; Dapsone; Female; Humans; Hypercalcemia; Leprosy; Middle | 1985 |